Left ventricular thrombus (LVT), often manifesting as an apical clot, is a serious complication associated with significant morbidity and mortality. Its formation is primarily linked to acute myocardial infarction (AMI) and various non-ischemic cardiomyopathies, leading to a substantial risk of systemic thromboembolism, particularly stroke. This article provides a comprehensive review of LVT, focusing on its causes, diagnosis, treatment guidelines from various authoritative bodies (including the NHS and ESC), and the crucial management strategies to mitigate the risk of devastating complications like stroke. This narrative literature review incorporates a manual search of reference lists from relevant articles to ensure a thorough examination of the available evidence.
Causes of Left Ventricular Thrombus:
The development of an LVT, frequently located apically, is intricately linked to the disruption of normal myocardial function and the subsequent cascade of events leading to thrombus formation. The primary etiological factors include:
* Acute Myocardial Infarction (AMI): AMI is the most common cause of LVT. The infarcted myocardial tissue undergoes necrosis, leading to akinesis or dyskinesis of the affected segment. This impaired myocardial contraction creates a stagnant environment within the left ventricle, predisposing to thrombus formation. The risk is particularly high in the first few weeks following AMI, with the apical region being a common site due to its relatively thin wall and susceptibility to impaired contractility. Larger infarcts significantly increase the risk.
* Non-Ischemic Cardiomyopathies: Various cardiomyopathies, including dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), and restrictive cardiomyopathy, can also lead to LVT formation. In these conditions, impaired ventricular function, reduced ejection fraction, and the presence of aneurysm or dyskinetic segments create a prothrombotic environment. The stagnant blood flow within these dysfunctional areas promotes thrombus formation.
* Left Ventricular Aneurysms: Left ventricular aneurysms, often a sequela of AMI, represent a significant risk factor for LVT development. The aneurysmal sac, with its irregular surface and stagnant blood flow, provides an ideal substrate for thrombus formation.
* Myocarditis: Inflammation of the myocardium can impair ventricular function, creating conditions conducive to thrombus formation.
* Valvular Heart Disease: Severe mitral or aortic valve disease can lead to left ventricular dysfunction and subsequent thrombus formation. The turbulent flow and pressure changes associated with valvular disease contribute to the development of LVT.
* Atrial Fibrillation: While not directly causing LVT, atrial fibrillation significantly increases the risk of systemic thromboembolism. Patients with both atrial fibrillation and LVT face a particularly high risk of stroke.
* Other Factors: Factors such as advanced age, diabetes mellitus, and hyperlipidemia can contribute to increased risk of both AMI and LVT formation.
Diagnosis of Left Ventricular Thrombus:
The diagnosis of LVT typically relies on echocardiography. Transthoracic echocardiography (TTE) is the initial imaging modality of choice, capable of visualizing intra-ventricular thrombi, especially apical clots. TTE offers a non-invasive approach, allowing for repeated assessments to monitor thrombus size and changes over time. However, TTE may have limitations in visualizing small or poorly echogenic thrombi.
current url：https://ouqgiv.e257z.com/blog/lv-apical-clot-1228
breitling navitimer montbrillant 01 blue dial comment nettoyer une rolex